@article{6982044018ea4303b3c966b86882d79a,
title = "Clinical implications of restrictions in criteria for defining surgical site infections after mastectomy",
abstract = "More than 50% of women with clinically apparent infection after mastectomy did not meet the 2020 National Healthcare Safety Network (NHSN) definition for surgical site infection (SSI). Implant loss was similar whether the 2020 NHSN SSI definition was met or not, suggesting equivalent adverse outcomes regardless of restriction to the surveillance definition.",
author = "Bediako-Bowan, {Antoinette A.A.} and Warren, {David K.} and Nickel, {Katelin B.} and Fraser, {Victoria J.} and Olsen, {Margaret A.}",
note = "Funding Information: Funding for this project was provided by the Centers for Disease Control and Prevention (grant no. U54CK000482 to V.J.F.). Funding Information: M.A.O. reports consultant work with Pfizer and grant funding through Pfizer, Merck, and Sanofi Pasteur for work outside the submitted manuscript. V.J.F. reports her spouse is the Chief Clinical Officer at Cigna Corporation. D.K.W. reports consultant work with Centene, PDI, Pursuit Vascular, Homburg & Partner, and Carefusion/BD and as a subinvestigator for a Pfizer-sponsored study for work outside the submitted manuscript. All other authors report no conflicts of interest relevant to this article. Publisher Copyright: {\textcopyright} 2021 Infection Control and Hospital Epidemiology. All rights reserved.",
year = "2021",
month = jun,
doi = "10.1017/ice.2020.1288",
language = "English",
volume = "42",
pages = "767--769",
journal = "Infection Control and Hospital Epidemiology",
issn = "0899-823X",
number = "6",
}